在癌症治疗中,M1巨细胞及其细胞外囊的作用
Wenli Zhou1, Fengtang Yang1, Xiuzhen Zhang1
1School of Life Sciences and Medicine, Shandong University of Technology, Zibo 255049, China.
Cells
|September 14, 2024
概括
由M1巨细胞衍生的细胞外囊泡 (M1-EVs) 通过输送微RNA和药物,在癌症治疗中表现有前途. 将M2巨细胞重新编程为M1也可能提高癌症治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 纳米医学是一种纳米医学.
背景情况:
- 瘤相关巨细胞 (TAMs) 是瘤微环境的关键组成部分,表现出功能异质性.
- TAMs存在于M1和M2亚群中,在免疫反应和组织修复中具有相反的作用.
- 细胞外囊泡 (EVs) 调解细胞间通信,从母细胞传递微RNA等分子载荷到细胞.
研究的目的:
- 审查M1巨衍生的EVs (M1-EVs) 在癌症治疗中的治疗潜力.
- 通过微RNA转移探索M1-EVs对瘤的影响.
- 讨论M1-EV作为药物输送工具以及将M2巨细胞重新编程到M1.
主要方法:
- 关于M1-EVs及其在癌症中的作用的文献综述.
- 通过M1-EVs进行微RNA转移机制的分析.
- 探索M2到M1巨细胞重编程策略.
主要成果:
- M1-EVs可以将microRNA转移到瘤细胞中,从而影响其行为.
- 在癌症治疗中,M1-EVs显示出作为向药物输送的载体的潜力.
- 将M2巨细胞重新编程为M1巨细胞是一个可行的治疗途径.
结论:
- 在癌症治疗中,M1-EVs通过微RNA输送和药物加载具有重要意义.
- 将M2巨细胞重新编程到M1为癌症治疗提供了一个有希望的策略.
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Mesenchymal Stem Cells
4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Tumor Immunotherapy
491
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
491
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K


